Core Insights - eXoZymes Inc. is a pioneer in AI-engineered enzymes that convert sustainable feedstock into nutraceuticals, medicines, and essential chemicals [1] Company Participation - eXoZymes will be presenting at the Spartan Capital Securities Investor Conference on November 3, 2025, at the Marriott Marquis Hotel in New York City [1] - The company's participation highlights the conference's focus on innovative companies and emerging market leaders poised for long-term growth [1]

Company Overview - eXoZymes Inc. is a pioneer in AI-engineered enzymes that convert sustainable feedstock into essential chemicals, medicines, and biofuels [1][3] - Founded in 2019, the company has developed a platform that optimizes natural processes for chemical production, offering a sustainable alternative to traditional methods [2] Upcoming Events - eXoZymes plans to host a webinar on April 2, 2025, at 4:30 p.m. Eastern Time to discuss its fourth quarter and full year 2024 results [1] - The CEO, Michael Heltzen, will lead the call along with select management team members to review recent developments and ongoing initiatives [1] Technology and Innovation - The company's exozymes are advanced enzymes enhanced with AI and bioengineering, designed to operate outside of living cells in bioreactors [3] - Exozymes provide sustainable and scalable biosolutions, replacing toxic petrochemical processes and inefficient biochemical extraction [3][4] - This technology addresses the scaling bottleneck that has hindered commercial success in the synthetic biology sector, marking a transition to the exozymes era of biotechnology [4]